1. Home
  2. BOLD vs WYY Comparison

BOLD vs WYY Comparison

Compare BOLD & WYY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLD
  • WYY
  • Stock Information
  • Founded
  • BOLD 2018
  • WYY 1991
  • Country
  • BOLD United States
  • WYY United States
  • Employees
  • BOLD N/A
  • WYY N/A
  • Industry
  • BOLD
  • WYY EDP Services
  • Sector
  • BOLD
  • WYY Technology
  • Exchange
  • BOLD Nasdaq
  • WYY Nasdaq
  • Market Cap
  • BOLD 30.3M
  • WYY 33.6M
  • IPO Year
  • BOLD 2024
  • WYY 1998
  • Fundamental
  • Price
  • BOLD $1.17
  • WYY $3.11
  • Analyst Decision
  • BOLD Buy
  • WYY Strong Buy
  • Analyst Count
  • BOLD 3
  • WYY 1
  • Target Price
  • BOLD $4.00
  • WYY $7.00
  • AVG Volume (30 Days)
  • BOLD 283.9K
  • WYY 75.7K
  • Earning Date
  • BOLD 08-11-2025
  • WYY 08-13-2025
  • Dividend Yield
  • BOLD N/A
  • WYY N/A
  • EPS Growth
  • BOLD N/A
  • WYY N/A
  • EPS
  • BOLD N/A
  • WYY N/A
  • Revenue
  • BOLD N/A
  • WYY $142,582,209.00
  • Revenue This Year
  • BOLD N/A
  • WYY $10.84
  • Revenue Next Year
  • BOLD N/A
  • WYY $12.37
  • P/E Ratio
  • BOLD N/A
  • WYY N/A
  • Revenue Growth
  • BOLD N/A
  • WYY 24.03
  • 52 Week Low
  • BOLD $1.00
  • WYY $2.19
  • 52 Week High
  • BOLD $4.72
  • WYY $6.25
  • Technical
  • Relative Strength Index (RSI)
  • BOLD N/A
  • WYY 42.75
  • Support Level
  • BOLD N/A
  • WYY $3.06
  • Resistance Level
  • BOLD N/A
  • WYY $3.46
  • Average True Range (ATR)
  • BOLD 0.00
  • WYY 0.18
  • MACD
  • BOLD 0.00
  • WYY 0.01
  • Stochastic Oscillator
  • BOLD 0.00
  • WYY 23.08

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

About WYY WidePoint Corporation

WidePoint Corp is a provider of Technology Management as a Service (TMaaS) that consists of federally certified communications management, identity management, interactive bill presentment and analytics, and an Information Technology as a Service solution. Its solutions include Telecom Lifecycle Management, Digital billing communications solutions, and Mobile and Identity management. Geographically, the company generates a majority of its revenue from the United States and the rest from Europe.

Share on Social Networks: